Category Archives: News

Dr. John Hoskins Discusses Age-Related Macular Degeneration

Date:

Dr. John Hoskins discusses on Educational TV Age-Related Macular Degeneration (AMD)  and what Southeastern Retina Associates is doing to treat this number 1 reason for blindness for those over 50. 

 

AMD is a type of macular degeneration that happens as the result of aging. It causes damage to the macula, a small spot near the center of the retina and the part of the eye needed for sharp, central vision, which lets us see objects that are straight ahead.

 

 

Recognized Nationally for Clinical Excellence

Date:

KNOXVILLE, TN (January 30, 2015): Southeastern Retina Associates recently received a prestigious industry award for its contributions to advancing medical research of diabetes-induced retinal disorders.  Southeastern Retina Associates was awarded the Top Site Award for 2014 and 2013 by the Diabetic Retinopathy Clinical Research (DRCR) Network for demonstrating outstanding performance in the DRCR Network.

“We are honored to be acknowledged again at this level for our clinical excellence,” said Dr. Joseph M. Googe, Jr. of Southeastern Retina Associates. “Our entire staff has always been committed to providing the finest care possible and offering our patients the newest and best treatments of vision-threatening diseases.”

The DRCR is a collaborative network funded by the National Eye Institute (NIH) and is dedicated to clinical research of diabetic retinopathy, diabetic macular edema and associated conditions. The DRCR includes over 120 participating sites (offices) with over 320 physicians throughout the United States.

“If you are diabetic and have vision issues, as a patient of Southeastern Retina Associates, you can be assured you have the most experienced medical team in the region working to preserve your eyesight,” said Googe. “We have been leading clinical trials for more than 15 years and continue to advance leading edge research to stay abreast of the latest refinements in surgical technique and scientific discovery for our patients.”

For patients who would like more information on enrolling in a clinical trial, please contact one of the Southeastern Retina Associates clinical trials coordinators:

Knoxville: Kristina Oliver & Lisa Lovelady, (865) 588-0811

Chattanooga: Steve McBee, (865) 756-1002

Tri-Cities: Deanna Long, (423) 578-4364

Southeastern Retina Associates is an ophthalmological practice of 14 board-certified vitreoretinal surgeons who specialize in the diagnosis, treatment and management of diseases of the retina, macula and vitreous of the eye such as macular degeneration, macular holes, diabetic retinopathy, detachment and tears of the retina and vitreous hemorrhage. Southeastern Retina Associates has central locations in Knoxville, Chattanooga and Tri-Cities, and other satellite offices in East Tennessee, Alabama, Georgia, Virginia, and the Cumberland Plateau.

Southeastern Retina Associates Partners With NIH in Clinical Trial

Date:

Southeastern Retina Associates is one of 100 sites across the country partnering with the National Institutes of Health (NIH) in a study of the use of the drug Eylea as an injectable eye treatment for diabetic patients with vision problems.

The study will evaluate the effectiveness of the new treatment compared to laser therapy, the current gold standard treatment for a complication of diabetic retinopathy in which patients suffer bleeding in the retina. The condition can result in blindness if not treated successfully.

Patients taking part in the study will get either injections of Eylea, laser therapy, or simply be observed for changes.

Steve Perkins, M.D., of Southeastern Retina Associates is recruiting diabetics whose vision remains relatively undamaged to participate in the study. Injections of Eylea are free, though patients or their insurance may be required to pay other costs involving regular eye care.

Patients interested in participating in the study may call 865-588-0811 for more information.